Cargando…
The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
SIMPLE SUMMARY: A new class of drugs, termed Immune Checkpoint Inhibitors, has revolutionized cancer therapy during the last few years. Unfortunately, these drugs are only effective for a subset of patients and cancer types. Recent work has suggested that how well cancer cells present some of their...
Autores principales: | Mpakali, Anastasia, Stratikos, Efstratios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796214/ https://www.ncbi.nlm.nih.gov/pubmed/33406696 http://dx.doi.org/10.3390/cancers13010134 |
Ejemplares similares
-
Can ERAP1 and ERAP2 Form Functional Heterodimers? A Structural Dynamics Investigation
por: Papakyriakou, Athanasios, et al.
Publicado: (2022) -
The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I
por: Mavridis, George, et al.
Publicado: (2021) -
The Role of Conformational Dynamics in Antigen Trimming by Intracellular Aminopeptidases
por: Papakyriakou, Athanasios, et al.
Publicado: (2017) -
Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018) -
Antigen processing and presentation in cancer immunotherapy
por: Lee, Maxwell Y, et al.
Publicado: (2020)